BERLIN and VENLO, The Netherlands, May 29, 2007 (PRIME NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) (Prime Standard:QIA) and Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) today announced that the companies further expanded their existing strategic partnership by a new license agreement.
